Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma

BACKGROUND AND PURPOSE: Pre-treatment ADC characteristics have been shown to predict response to bevacizumab in recurrent glioblastoma multiforme. However, no studies have examined whether ADC characteristics are specific to this particular treatment. The purpose of the current study was to determin...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:AJNR Am J Neuroradiol
Auteurs principaux: Ellingson, B.M., Sahebjam, S., Kim, H.J., Pope, W.B., Harris, R.J., Woodworth, D.C., Lai, A., Nghiemphu, P.L., Mason, W.P., Cloughesy, T.F.
Format: Artigo
Langue:Inglês
Publié: American Society of Neuroradiology 2014
Sujets:
Brain
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7965805/
https://ncbi.nlm.nih.gov/pubmed/24136647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A3748
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires